Coronary heart disease as a case study in prevention: potential role of incentives

Philip A Ades1, Diann E Gaalema

  • 1Division of Cardiology, University of Vermont College of Medicine, University Health Center Campus, 1 S. Prospect St, Burlington, VT 05401, USA. Philip.ades@vtmednet.org

Preventive Medicine
|January 31, 2012
PubMed

Insights

Monetary incentives may encourage healthier behaviors to prevent and treat coronary heart disease. This review explores using financial rewards, especially for cardiac rehabilitation (CR), to improve patient outcomes.

Area of Science:

  • Cardiology and Behavioral Economics

Background:

  • Coronary atherosclerosis stems from behavioral, genetic, and environmental factors.
  • Key risk factors for coronary heart disease (CHD) include tobacco use, hyperlipidemia, hypertension, obesity, insulin resistance, diabetes, and physical inactivity.

Purpose of the Study:

  • To review the potential role of monetary incentives in preventing and treating coronary heart disease.
  • To highlight the specific application of incentives for patient participation in cardiac rehabilitation (CR).

Main Methods:

  • Literature review on the intersection of behavioral economics and cardiovascular disease prevention.
  • Analysis of existing research on financial incentives and health behavior change.
  • Exploration of CR as a multi-risk intervention amenable to incentive-based strategies.

Main Results:

  • Behavioral factors significantly contribute to CHD risk.
  • Monetary incentives represent an underutilized strategy for promoting heart-healthy behaviors.
  • Cardiac rehabilitation offers a promising avenue for implementing incentive programs to improve patient adherence and outcomes.

Conclusions:

  • Financial incentives show potential for enhancing the prevention and treatment of coronary heart disease.
  • Integrating monetary incentives into cardiac rehabilitation programs could improve patient engagement and cardiovascular health.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...